Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors: A Retrospective Analysis
Xiaona Fu,1– 3,* Shanshan Jiang,1– 3,* Yi Li,1– 3,* Yusheng Guo,1– 3 Bingxin Gong,1– 3 Jie Lou,1– 3 Yanlin Li,4 Sichen Wang,5 Yuxin Sun,1– 3 Yi Ren,1– 3 Quan Chen,1– 3 Lian Yang1– 3 1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong Univers...
Saved in:
Main Authors: | Fu X, Jiang S, Li Y, Guo Y, Gong B, Lou J, Wang S, Sun Y, Ren Y, Chen Q, Yang L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-05-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/spleen-volume-dynamics-and-survival-outcomes-in-hcc-patients-undergoin-peer-reviewed-fulltext-article-JHC |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting recurrence and recurrence-free survival in initially unresectable hepatocellular carcinoma: a novel nomogram for patients undergoing conversion hepatectomy with lenvatinib, PD-1 inhibitor, and interventional therapy
by: Cheng Xu, et al.
Published: (2025-07-01) -
Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patients
by: Eman M. F. Barakat, et al.
Published: (2025-06-01) -
The Higher Incidence of Liver Injury in HCC Patients Compared to Other Malignancies During Immune-Checkpoint Inhibitor Therapy is Primarily Due to Tumor Progression
by: Wang Y, et al.
Published: (2025-06-01) -
Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC
by: Bowen Liu, et al.
Published: (2025-07-01) -
A Novel Nomogram for Prediction of Survival in Patients with Small Isolated Hepatocellular Carcinoma: A Population-Based and Externally Validated Study
by: Ziqiang Li, et al.
Published: (2025-12-01)